Contrave

Tennessee company in battle with European regulators over weight-loss drug
Axios
Tue, 12/19/23 - 10:25 am
Currax
Europe
weight loss
Contrave
Mysimba
Ozempic
Orexigen’s Weight-Loss Roller Coaster to End With a Bankruptcy Sale
Xconomy
Mon, 03/12/18 - 09:47 am
Orexigen
bankruptcy
Contrave
Troubled Orexigen looks for a buyer, but will anyone want Contrave?
Fierce Pharma
Thu, 10/19/17 - 11:33 am
Orexigen Therapeutics
Contrave
M&A
Orexigen posts a ‘for sale’ sign in the yard as weak Contrave sales raise concerns
Endpoints
Tue, 10/17/17 - 09:50 am
Orexigen
Contrave
M&A
The FDA cites risk info in letter over Contrave DTC ad
Medical Marketing and Media
Thu, 05/25/17 - 08:54 am
FDA
Contrave
drug ads
Orexigen Therapeutics
Orexigen - Contrave Sales Present Troubling Data
Seeking Alpha
Tue, 06/21/16 - 11:21 am
Orexigen
Contrave
obesity
Orexigen struggles to stay afloat as obesity market stagnates
BioPharma Dive
Thu, 05/19/16 - 09:43 am
Orexigen
obesity
Contrave
Vivus
Qsymia
Takeda
Orexigen Pulls The Plug On Post-Marketing Cardiovascular Trial
Seeking Alpha
Sat, 04/16/16 - 04:27 pm
Orexigen
Contrave
Orexigen: Contrave Sales Flatten Out At End Of Q1
Seeking Alpha
Mon, 04/11/16 - 09:58 am
Orexigen
Contrave
obesity
Novo Nordisk
Vivus
Arena Pharmaceuticals
Orexigen buys U.S. obesity pill rights from Takeda, partners Valeant
Yahoo/Reuters
Tue, 03/15/16 - 09:32 am
Orexigen
obesity
Contrave
Takeda
Valeant Pharmaceuticals
M&A
Orexigen takes another body blow from ill-fated Contrave trial
Fierce Pharma
Wed, 03/9/16 - 03:40 pm
Orexigen
Contrave
obesity
Takeda
clinical trials
Hoping Vivus and Orexigen can finally kick-start their obesity meds? Don't count on it, analyst says
Fierce Pharma Marketing
Tue, 03/1/16 - 10:56 pm
obesity
Vivus
Orexigen
Contrave
Qsymia
Takeda
Are Takeda's 900 Contrave reps worth it? Maybe not, analyst says
Fierce Pharma Marketing
Mon, 11/9/15 - 03:38 pm
Takeda
Contrave
drug reps
Orexigen
Contrave script growth snags, despite Takeda's 900-strong salesforce
Fierce Pharma Marketing
Tue, 09/29/15 - 09:16 am
Contrave
Takeda
Orexigen
obesity
Why Hasn't Orexigen Launched Its Obesity Drug in Europe Yet?
Motley Fool
Sat, 09/19/15 - 09:14 am
Orexigen
Europe
drug launches
obesity
Mysimba
Contrave
Here's What Caused Orexigen Therapeutics to Slim Down in August
Motley Fool
Mon, 09/7/15 - 11:44 am
Orexigen Therapeutics
Takeda
Contrave
Orexigen - Contrave Takes Sales Lead In The U.S. - More Sales Still Needed
Seeking Alpha
Mon, 06/22/15 - 12:49 pm
Orexigen
Contrave
obesity
Arena Pharmaceuticals
Vivus
Brutal honesty in drug marketing? For obesity meds, it's key to avoiding the 'magic pill' trap
Fierce Pharma Marketing
Mon, 06/8/15 - 12:13 pm
obesity
Takeda
Contrave
Orexigen
Vivus
Qsymia
Eisai
Belviq
Arena Pharmaceuticals
Orexigen, Takeda take Actavis to court over obesity med Contrave generic
BioPharma Dive
Mon, 06/8/15 - 11:03 am
Orexigen
Takeda
Actavis
obesity
generics
Contrave
Orexigen and Takeda File Lawsuit Against Actavis for Infringement of Contrave® Patents
Yahoo
Fri, 06/5/15 - 09:13 am
Orexigen
Takeda
Actavis
patents
Contrave

Pages